Adaptive Biotechnologies (ADPT) Cash from Operations (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Cash from Operations of 9537000.0 for Q1 2026, down 564.09% sequentially from 2055000.0 in Q4 2025, and up 66.52% YoY from 5727307.2 in Q1 2025.
Adaptive Biotechnologies (ADPT) Cash from Operations (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Cash from Operations data on file, last reported at 9537000.0 in Q1 2026.
- Quarterly Cash from Operations rose 66.52% year-over-year to 9537000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 27039000.0 (up 68.32% YoY) and the FY2025 annual result came in at 45986000.0, up 51.7% from the prior year.
- Cash from Operations declined to 9537000.0 in Q1 2026 per ADPT's latest filing, from 2055000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2055000.0 in Q4 2025, with the low at 64453000.0 in Q1 2022.
- Average Cash from Operations over 5 years is 28882588.24, with a median of 27065000.0 recorded in 2024.
- Year-over-year, Cash from Operations decreased 26.47% in 2022 and soared 116.45% in 2025.
- Adaptive Biotechnologies' Cash from Operations stood at 30019000.0 in 2022, then advanced by 10.28% to 26932000.0 in 2023, then soared by 53.62% to 12491000.0 in 2024, then soared by 116.45% to 2055000.0 in 2025, then plunged by 564.09% to 9537000.0 in 2026.
- Business Quant data shows ADPT's Cash from Operations at 9537000.0 in Q1 2026, 2055000.0 in Q4 2025, and 7127000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.19 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 1.32 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 266.25 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 40.17 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 277.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 618.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 289.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 139.79 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -9.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.54 Mn |
| Mar 31, 2026 | -9.54 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Dec 31, 2025 | 2.06 Mn |
| Sep 30, 2025 | -7.13 Mn |
| Sep 30, 2025 | -7.13 Mn |
| Jun 30, 2025 | -12.43 Mn |
| Jun 30, 2025 | -12.43 Mn |
| Mar 31, 2025 | -28.48 Mn |
| Mar 31, 2025 | -28.48 Mn |
| Dec 31, 2024 | -12.49 Mn |
| Dec 31, 2024 | -12.49 Mn |
| Sep 30, 2024 | -27.07 Mn |
| Sep 30, 2024 | -27.07 Mn |
| Jun 30, 2024 | -17.30 Mn |
| Jun 30, 2024 | -17.30 Mn |
| Mar 31, 2024 | -38.35 Mn |
| Mar 31, 2024 | -38.35 Mn |
| Dec 31, 2023 | -26.93 Mn |
| Dec 31, 2023 | -26.93 Mn |